Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2016, Vol. 7 Issue (6) : 687-690     DOI: 10.14336/AD.2016.0402
Short Communications |
Association between Serum Magnesium Levels and Depression in Stroke Patients
Gu Yingying, Zhao Kai, Luan Xiaoqian, Liu Zhihua, Cai Yan, Wang Qiongzhang, Zhu Beilei*, He Jincai*
Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejinag, China
Download: PDF(704 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

Post-stroke depression (PSD) is a common psychiatric complication of stroke that is associated with a poor outcome in stroke patients. Our aim was to assess the association between the serum magnesium levels and the presence of PSD in Chinese patients. Two hundred nine stroke patients were included in the study. Depressive symptoms were measured by the 17-Hamilton Rating Scale for Depression at 3 months after stroke. Based on the depressive symptoms, diagnoses of depression were made in line with the DSM-IV criteria for PSD. Serum magnesium levels were evaluated using the dimethyl aniline blue colorimetric method at admission. Multivariate analyses were conducted using logistic regression models. Further, 120 normal subjects were recruited, and their serum magnesium levels were also measured as control. At 3 months, fifty-nine patients (28.2%) were diagnosed as PSD. The serum magnesium levels were significantly lower in both PSD patients and non-PSD patients than in normal subjects (p < 0.001). Indeed, patients with PSD showed lower serum magnesium levels (p < 0.001) than did non-PSD patients at admission. In the multivariate analyses, after adjusting for potential variables, we found that an increased risk of PSD was associated with serum magnesium levels ≤ 0.84mmol/L (OR 2.614, 95% CI 1.178-5.798, p=0.018). Low serum magnesium levels at admission were found to be associated with the presence of PSD at 3 months after stroke.

Keywords magnesium      depression      stroke      biochemical marker     
Corresponding Authors: Zhu Beilei,He Jincai   
About author:

These authors contributed equally to this work

Issue Date: 01 December 2016
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Gu Yingying
Zhao Kai
Luan Xiaoqian
Liu Zhihua
Cai Yan
Wang Qiongzhang
Zhu Beilei
He Jincai
Cite this article:   
Gu Yingying,Zhao Kai,Luan Xiaoqian, et al. Association between Serum Magnesium Levels and Depression in Stroke Patients[J]. Aging and disease, 2016, 7(6): 687-690.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2016.0402     OR     http://www.aginganddisease.org/EN/Y2016/V7/I6/687
Non-PSD (n = 150)PSD (n = 59)Control (n = 120)
Demographic characteristics
Age (years), mean ± SD60.41±10.6362.39 ± 9.6659.47 ± 9.35
Female (%)39(26.0)30 (50.8)b d39 (32.5)
BMI (kgm-2), mean ± SD24.00±3.1324.69 ± 3.32
Education (years), median (IQR)5(1-7)3 (0-7)
Vascular risk factors (%)
  Hypertension139(92.7)54 (91.5)
  Diabetes mellitus41(27.3)29 (49.2)b
  Hyperlipidaemia72(48.0)33 (55.9)
  Coronary heart disease4(2.7)4 (6.8)
  History of stroke15(10.0)8 (13.6)
  Current smoking57(38.3)15 (27.8)
  Alcohol consumption61(41.5)15 (27.8)
  Systolic blood pressure (mmHg), mean ± SD157.12±22.78160.63 ± 22.52
  Diastolic blood pressure(mmHg), mean ± SD86.90±13.3784.31 ± 12.17
Lesion location
  Frontal lobe33 (22.0)11 (18.6)
  Parietal lobe29 (19.3)13 (22.0)
  Temporal lobe17 (11.3)8 (13.6)
  Occipital lobe20 (13.3)7 (11.9)
  Basal ganglia62 (41.3)27 (45.8)
  Brainstem23 (15.3)11 (18.6)
  Cerebellum7 (4.7)4 (6.8)
  Other78 (52.0)30 (50.8)
Neuropsychological function
  NIHSS at admission, median (IQR)3 (1-4)3.5 (2-6)b
mRS at discharge, median (IQR)1 (1-2)2 (1-3)b
Mg2+ (mmolL-1), median (IQR)0.88 (0.84 - 0.94)d0.84 (0.77-0.87)ac0.96 (0.84 - 1.07)
Mg2+ (mmolL-1), mean ± SD0.89 ± 0.10d0.83 ± 0.09ac0.94 ± 0.13
Table 1  Baseline clinical characteristics in patients with and without post-stroke depression at 3-months.
Non-PSD (n=150)PSD (n=59)p
Mg2+ category, n (% of total population)0.013
  Low tertile (≤0.84mmol/L)45(30.0%)30(50.8%)0.005
  Intermediate tertile (0.85-0.89 mmol/L)59(39.3%)19(32.2)0.337
  High tertile (≥0.90mmol/L)46(30.7%)10(16.9%)0.044
Table 2  Magnesium levels tertiles of patients
VariablesOR (95% CI)p
Magnesium0.006
  Low tertile2.614 (1.178-5.798)0.018
  High tertile0.579 (0.225-1.494)0.259
sex3.447 (1.702-6.981)0.001
NIHSS on admission1.151 (0.969-1.369)0.110
mRS at discharge1.534 (1.033-2.278)0.34
DM1.495 (0.734-3.044)0.267
Table 3  Multivariate logistic model of the clinical determinants of PSD
[1] Hackett ML, Yapa C, Parag V, Anderson CS (2005). Frequency of depression after stroke - A systematic review of observational studies. Stroke, 36: 1330-1340
[2] Ayerbe L, Ayis S, Crichton S, Wolfe CDA, Rudd AG (2014). The long-term outcomes of depression up to 10 years after stroke; the South London Stroke Register. J Neurol Neurosurg Psychiatry, 85: 514-521
[3] Ayerbe L, Ayis S, Wolfe CD, Rudd AG (2013). Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry, 202: 14-21
[4] Winther G, Pyndt Jorgensen BM, Elfving B, Nielsen DS, Kihl P, Lund S, et al. (2015). Dietary magnesium deficiency alters gut microbiota and leads to depressive-like behaviour. Acta Neuropsychiatr, 27: 168-176
[5] Pochwat B, Szewczyk B, Sowa-Kucma M, Siwek A, Doboszewska U, Piekoszewski W, et al. (2014). Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits. Int J Neuropsychopharmacol, 17: 393-405
[6] Sluijs I, Czernichow S, Beulens JW, Boer JM, van der Schouw YT, Verschuren WM, et al. (2014). Intakes of potassium, magnesium, and calcium and risk of stroke. Stroke, 45: 1148-1150
[7] Nie ZL, Wang ZM, Zhou B, Tang ZP, Wang SK (2013). Magnesium intake and incidence of stroke: meta-analysis of cohort studies. Nutr Metab Cardiovasc Dis, 23: 169-176
[8] Larsson SC, Virtamo J, Wolk A (2011). Potassium, calcium, and magnesium intakes and risk of stroke in women. Am J Epidemiol, 174: 35-43
[9] Adebamowo SN, Spiegelman D, Flint AJ, Willett WC, Rexrode KM (2015). Intakes of magnesium, potassium, and calcium and the risk of stroke among men. Int J Stroke, 10: 1093-1100
[10] Cheng SY, Zhao YD, Li J, Chen XY, Wang RD, Zeng JW (2014). Plasma levels of glutamate during stroke is associated with development of post-stroke depression. Psychoneuroendocrinology, 47: 126-135
[11] Li J, Zhao YD, Zeng JW, Chen XY, Wang RD, Cheng SY (2014). Serum Brain-derived neurotrophic factor levels in post-stroke depression. J Affect Disord, 168: 373-379
[12] Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry, 23: 56-62
[13] Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A (1984). Magnesium gates glutamate-activated channels in mouse central neurones. Nature, 307: 462-465
[14] Moykkynen T, Uusi-Oukari M, Heikkila J, Lovinger DM, Luddens H, Korpi ER (2001). Magnesium potentiation of the function of native and recombinant GABA(A) receptors. Neuroreport, 12: 2175-2179
[15] Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, et al. (2011). NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature, 475: 91-95
[16] Pittenger C, Sanacora G, Krystal JH (2007). The NMDA receptor as a therapeutic target in major depressive disorder. CNS Neurol Disord Drug Targets, 6: 101-115
[1] Yang Hua,Lingyun Jia,Yingqi Xing,Pinjing Hui,Xuan Meng,Delin Yu,Xiaofang Pan,Yalan Fang,Binbin Song,Chunxia Wu,Chunmei Zhang,Xiufang Sui,Youhe Jin,Jingfen Zhang,Jianwei Li,Ling Wang,Yuming Mu,Jingxin Zhong,Yuhong Zhu,Heng Zhang,Xiaoyu Cai. Distribution Pattern of Atherosclerotic Stenosis in Chinese Patients with Stroke: A Multicenter Registry Study[J]. Aging and disease, 2019, 10(1): 62-70.
[2] Fan Liu, Jianfei Lu, Anatol Manaenko, Junjia Tang, Qin Hu. Mitochondria in Ischemic Stroke: New Insight and Implications[J]. Aging and disease, 2018, 9(5): 924-937.
[3] Zhu Shuzhen, Gao Xiaoya, Huang Kaibin, Gu Yong, Hu Yafang, Wu Yongming, Ji Zhong, Wang Qing, Pan Suyue. Glibenclamide Enhances the Therapeutic Benefits of Early Hypothermia after Severe Stroke in Rats[J]. Aging and disease, 2018, 9(4): 685-695.
[4] Yan Tao, Venkat Poornima, Chopp Michael, Zacharek Alex, Yu Peng, Ning Ruizhuo, Qiao Xiaoxi, Kelley Mark R., Chen Jieli. APX3330 Promotes Neurorestorative Effects after Stroke in Type One Diabetic Rats[J]. Aging and disease, 2018, 9(3): 453-466.
[5] Zhang Zheng, Zhang Linlei, Ding Yuchuan, Han Zhao, Ji Xunming. Effects of Therapeutic Hypothermia Combined with Other Neuroprotective Strategies on Ischemic Stroke: Review of Evidence[J]. Aging and disease, 2018, 9(3): 507-522.
[6] Liu Xiangrong, Wen Shaohong, Zhao Shunying, Yan Feng, Zhao Shangfeng, Wu Di, Ji Xunming. Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP[J]. Aging and disease, 2018, 9(3): 401-411.
[7] Deng Qi-Wen, Li Shuo, Wang Huan, Lei Leix, Zhang Han-Qing, Gu Zheng-Tian, Xing Fang-Lan, Yan Fu-Ling. The Short-term Prognostic Value of the Triglyceride-to-high-density Lipoprotein Cholesterol Ratio in Acute Ischemic Stroke[J]. Aging and disease, 2018, 9(3): 498-506.
[8] Zhang Yu, Zhang Hongxia, Lin Siyang, Chen Xudong, Yao Yu, Mao XiaoOu, Shao Bei, Zhuge Qichuan, Jin Kunlin. SDF-1/CXCR7 Chemokine Signaling is Induced in the Peri-Infarct Regions in Patients with Ischemic Stroke[J]. Aging and disease, 2018, 9(2): 287-295.
[9] Wu Chuanjie, Wu Di, Chen Jian, Li Chuanhui, Ji Xunming. Why not Intravenous Thrombolysis in Patients with Recurrent Stroke within 3 Months?[J]. Aging and disease, 2018, 9(2): 309-316.
[10] Li Guangwen, Ma Qingfeng, Wang Rongliang, Fan Zhibin, Tao Zhen, Liu Ping, Zhao Haiping, Luo Yumin. Diagnostic and Immunosuppressive Potential of Elevated Mir-424 Levels in Circulating Immune Cells of Ischemic Stroke Patients[J]. Aging and disease, 2018, 9(2): 172-781.
[11] Pan Mengxiong, Wang Peng, Zheng Chengcai, Zhang Hongxia, Lin Siyang, Shao Bei, Zhuge Qichuan, Jin Kunlin. Aging Systemic Milieu Impairs Outcome after Ischemic Stroke in Rats[J]. Aging and disease, 2017, 8(5): 519-530.
[12] Xu Xianglai, Wang Brian, Ren Changhong, Hu Jiangnan, Greenberg David A., Chen Tianxiang, Xie Liping, Jin Kunlin. Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases[J]. Aging and disease, 2017, 8(4): 486-505.
[13] Hussain Mohammed, Datta Neil, Cheng Zhe, Dornbos David, Bashir Asif, Sultan Ibrahim, Mehta Tapan, Shweikeh Faris, Mazaris Paul, Lee Nora, Nouh Amre, Geng Xiaokun, Ding Yuchuan. Spanning from the West to East: An Updated Review on Endovascular Treatment of Intracranial Atherosclerotic Disease[J]. Aging and disease, 2017, 8(2): 196-202.
[14] Liu Junfeng, Wang Deren, Xiong Yao, Liu Bian, Lin Jing, Zhang Shihong, Wu Bo, Wei Chenchen, Liu Ming. Association between Coagulation Function and Cerebral Microbleeds in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease[J]. Aging and disease, 2017, 8(2): 131-135.
[15] Li Yun, Mei Zhu, Liu Shuiqiao, Wang Tong, Li Hui, Li Xiao-Xiao, Han Song, Yang Yutao, Li Junfa, Xu Zhi-Qing David. Galanin Protects from Caspase-8/12-initiated Neuronal Apoptosis in the Ischemic Mouse Brain via GalR1[J]. Aging and disease, 2017, 8(1): 85-100.
Viewed
Full text


Abstract

Cited

  Shared   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd